GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+45.46%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$1.24B
AUM Growth
+$1.24B
(+40%)
Cap. Flow
+$232M
Cap. Flow
% of AUM
18.66%
Top 10 Holdings %
Top 10 Hldgs %
65.34%
Holding
43
New
11
Increased
12
Reduced
7
Closed
8
Top Buys
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$57.6M |
| 2 |
Akebia Therapeutics
AKBA
|
$47.7M |
| 3 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$45.2M |
| 4 |
MacroGenics
MGNX
|
$41.9M |
| 5 |
Iovance Biotherapeutics
IOVA
|
$36.7M |
Top Sells
| 1 |
PTC Therapeutics
PTCT
|
$72.7M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$45.5M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
$31.4M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$26.6M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$17.1M |
Sector Composition
| 1 | Healthcare | 98.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALA
26
DELISTED
Calithera Biosciences, Inc
CALA
| $11.9M | 0.95% |
+2,261,700
| New | +$11.9M |
|
27
Liquidia Corp
LQDA
$2.52B
| $10.8M | 0.86% |
1,277,955
| – | – |
|
28
Denali Therapeutics
DNLI
$2.24B
| $6.77M | 0.54% |
+280,000
| New | +$6.77M |
|
|
VRAY
29
DELISTED
ViewRay, Inc.
VRAY
| $6.21M | 0.5% |
2,773,811
| – | – |
|
|
OYST
30
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $6.2M | 0.5% |
+214,631
| New | +$6.2M |
|
|
XLRN
31
DELISTED
Acceleron Pharma Inc.
XLRN
| $5.53M | 0.44% |
58,056
-477,571
| -89% | -$45.5M |
|
|
KDMN
32
DELISTED
Kadmon Holdings, Inc.
KDMN
| $3.46M | 0.28% |
+675,679
| New | +$3.46M |
|
33
Tempest Therapeutics
TPST
$46.6M
| $2.57M | 0.21% |
1,460,697
-269,062
| -16% | -$474K |
|
34
Puma Biotechnology
PBYI
$258M
| $965K | 0.08% |
+92,502
| New | +$965K |
|
35
Neurogene
NGNE
$284M
| $233K | 0.02% |
14,065
-26,282
| -65% | -$436K |
|
|
MNTA
36
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| – | – |
-979,400
| Closed | -$26.6M |
|
|
MYOK
37
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| – | – |
-364,163
| Closed | -$17.1M |
|
|
CCXI
38
DELISTED
ChemoCentryx, Inc.
CCXI
| – | – |
-357,379
| Closed | -$14.4M |
|
|
ABMD
39
DELISTED
Abiomed Inc
ABMD
| – | – |
-216,144
| Closed | -$31.4M |
|
40
VYNE Therapeutics
VYNE
$8.09M
| – | – |
-1,652,013
| Closed | -$4.43M |
|
41
Kura Oncology
KURA
$732M
| – | – |
-179,700
| Closed | -$1.79M |
|
42
Axsome Therapeutics
AXSM
$6.09B
| – | – |
-100,100
| Closed | -$5.89M |
|
43
Arvinas
ARVN
$580M
| – | – |
-118,330
| Closed | -$4.77M |
|